Molecular, histological, and clinical phenotyping of diabetic nephropathy: valuable complementary information?

Area of Science:

• Nephrology
• Endocrinology
• Genomics

Background:

• Increasing incidence and prevalence of diabetic kidney disease globally.
• Recognized variability in disease pathophysiology among individuals and over time.
• Significant clinical need for understanding molecular drivers of diabetic kidney disease.

Purpose of the Study:

• To explore the potential of "omics" technologies for characterizing diabetic kidney disease.
• To investigate the use of bioinformatic tools for patient stratification.
• To enhance prognosis prediction and guide targeted therapeutic strategies.

Main Methods:

• Integration of multi-omics data (genomics, proteomics, metabolomics, etc.).
• Application of advanced bioinformatic and statistical analyses.
• Comparative analysis of patient cohorts.

Main Results:

• Demonstrated feasibility of molecular profiling in diabetic kidney disease.
• Identified potential molecular signatures associated with disease progression.
• Highlighted heterogeneity in molecular pathways.

Conclusions:

• "Omics" approaches offer a powerful tool for understanding diabetic kidney disease complexity.
• Individualized molecular profiling can improve patient risk stratification.
• This strategy holds promise for developing targeted therapies and improving clinical management.